Developing Allogeneic Double Negative T Cells as a Novel Off-The-Shelf Adoptive Cellular Therapy for Cancer
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-18-2291
Full Text
Open PDFAbstract
Available in full text
Date
January 7, 2019
Authors
Publisher
American Association for Cancer Research (AACR)